CLINICAL TRIALS PROFILE FOR TRIZIVIR
✉ Email this page to a colleague
All Clinical Trials for Trizivir
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00004981 ↗ | Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir) | Unknown status | Glaxo Wellcome | Phase 3 | 1969-12-31 | The purpose of this study is to look at the safety and effectiveness of a pill called Trizivir that is a combination of three anti-HIV drugs (zidovudine, lamivudine, and abacavir). Zidovudine and lamivudine are often given combined in one pill (Combivir). In this study, Trizivir will be compared to Combivir plus abacavir. |
NCT00011895 ↗ | Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs | Unknown status | GlaxoSmithKline | Phase 4 | 2001-02-01 | The purpose of this study is to determine the effect of treatment with Trizivir (TZV) plus efavirenz (EFV) or TZV alone on viral load (level of HIV in the blood). |
NCT00038506 ↗ | Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure | Completed | ViiV Healthcare | Phase 4 | 2002-03-01 | This study is a 48-week study to evaluate the efficacy and safety of an investigational regimen combining FDA approved HIV drugs in antiretroviral-experienced subjects failing on their first highly active antiretroviral therapy regimen. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Trizivir
Condition Name
Clinical Trial Locations for Trizivir
Trials by Country
Clinical Trial Progress for Trizivir
Clinical Trial Phase
Clinical Trial Sponsors for Trizivir
Sponsor Name